about
Pesticide use practices in rural ArmeniaDetection of vancomycin-resistant enterococci (VRE) at four U.S. wastewater treatment plants that provide effluent for reuseMethicillin-resistant Staphylococcus aureus (MRSA) detected at four U.S. wastewater treatment plantsOccupational exposure to Staphylococcus aureus and Enterococcus spp. among spray irrigation workers using reclaimed waterOccurrence of vancomycin-resistant and -susceptible Enterococcus spp. in reclaimed water used for spray irrigationEvaluation of the relationship between the Adenosine Triphosphate (ATP) bioluminescence assay and the presence of Bacillus anthracis spores and vegetative cellsIsolation of antibiotic-resistant bacteria from the air plume downwind of a swine confined or concentrated animal feeding operationLung function impact from working in the pre-revolution Libyan quarry industryU.S. Ebola Treatment Center Clinical Laboratory Support.Current Capabilities and Capacity of Ebola Treatment Centers in the United States.Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease.Environmental infection control considerations for Ebola.Nebraska Biocontainment Unit patient discharge and environmental decontamination after Ebola care.Modeling risk of occupational zoonotic influenza infection in swine workers.Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers.Antibiotic Concentrations Decrease during Wastewater Treatment but Persist at Low Levels in Reclaimed Water.Gaseous chlorine dioxide as an alternative for bedbug control.Characterization of Viral Load, Viability and Persistence of Influenza A Virus in Air and on Surfaces of Swine Production Facilities.Higher prevalence of coagulase-negative staphylococci carriage among reclaimed water spray irrigators.Seasonal evaluation of fine and coarse culturable bacterial aerosols from residences within a rural and an urban city in Egypt.Characterization of methicillin-resistant Staphylococcus aureus isolated at Tripoli Medical Center, Libya, between 2008 and 2014.Evaluation of ambulance decontamination using gaseous chlorine dioxide.Isolation of airborne oxacillin-resistant Staphylococcus aureus from culturable air samples of urban residences.A Highly Infectious Disease Care Network in the US Healthcare System.A gap analysis of the United States death care sector to determine training and education needs pertaining to highly infectious disease mitigation and management.Personal protective equipment processes and rationale for the Nebraska Biocontainment Unit during the 2014 activations for Ebola virus disease.Transport and Management of Patients With Confirmed or Suspected Ebola Virus Disease.Surrogate testing suggests that chlorine dioxide gas exposure would not inactivate Ebola virus contained in environmental blood contamination.Planning and response to Ebola virus disease: An integrated approach.Nebraska Biocontainment Unit perspective on disposal of Ebola medical waste.Considerations for safe EMS transport of patients infected with Ebola virus.An integrated approach to laboratory testing for patients with Ebola virus disease.Ultraviolet (UV)-reflective paint with ultraviolet germicidal irradiation (UVGI) improves decontamination of nosocomial bacteria on hospital room surfaces.Evaluating Isolation Behaviors by Nurses Using Mobile Computer Workstations at the Bedside.Comparison of hospital room surface disinfection using a novel ultraviolet germicidal irradiation (UVGI) generator.Clinical challenges in isolation care.Decontamination of a hospital room using gaseous chlorine dioxide: Bacillus anthracis, Francisella tularensis, and Yersinia pestis.Method for investigating nursing behaviors related to isolation care.A pilot survey of the U.S. medical waste industry to determine training needs for safely handling highly infectious waste.Mathematical modeling of pathogen trajectory in a patient care environment.
P50
Q23910104-1ACB0C52-2E1B-41B4-BEFE-917DCE4C37E5Q23919876-3F6F61DF-8BD1-4F33-9E93-A94547C9772BQ23919877-19892B58-5537-4AFE-9EEF-BDA7B89BD13DQ23919878-F49B126D-0972-4D00-ABD3-6A77567929B7Q27908454-BAAA0EF4-3B11-4F82-8578-3640437BC327Q28389194-6751E196-CAA9-48DB-821C-36294E86A83FQ28389599-D754BFF6-B257-4C82-B60C-9249BC166DDEQ28395531-198236B1-47BC-4AA5-A436-08F52F69FFECQ30196765-E2614E7C-BB1F-4A47-9720-4BB749014E07Q30201953-98BE3AD8-D37E-4C28-B6D5-A0C50158DC4BQ30203624-686AA04E-0038-4D43-90AF-9EA6CA024EBFQ30203911-FD9197A8-3E39-418A-92D2-E621295E87CAQ30204923-388F9AC3-34F0-4EC6-B261-866869A3233FQ30385360-0243ED88-78D3-491B-A958-97E0C462BBA8Q33724629-750D7C35-EEBE-4C98-AE99-4B1477D38141Q33840073-DF8BF1D1-5F82-4B8B-97F6-C2A64A57133FQ34265944-CD3C1619-C0FD-4C13-9E5B-468BAE5CC584Q35891726-E3733FD3-E420-42C0-846F-2714B75F5C64Q38855471-9072A884-AE6F-4A3C-AD9D-64B232BEB9B9Q38884525-44B554A6-C51C-4186-868A-5ECFCFB9F772Q38903291-DCA0525F-56E0-4F38-8BC1-D428B2DFBC90Q39407724-D0490237-5879-443E-9B0C-C974570DAE4AQ39967494-B2E65A82-9DF1-4657-A8B8-7499F49D7185Q40051728-2EAA5F94-62B0-4ED8-8720-C313205BC2C6Q40052827-10B74CD8-992F-4597-9706-4BB3DBDC473CQ40131296-E134CB8E-ADDF-4999-9F60-B003BF6B4C83Q40154834-DBB599CC-B388-4D70-AA15-09DAAAB8C9E8Q40156929-2A9D8D66-B1C2-4849-8E31-D18764923BB0Q40157002-3219A050-9694-481D-B077-591529C07908Q40179754-4B3DAF71-BB82-48BE-B8B3-01260832742BQ40183711-F780B114-CEEA-43FB-83CE-34C079E1C51DQ40185311-7D4E8241-40C0-4A40-A6BF-4355505DBF65Q40300954-9B4FFDBF-A08E-4E04-9232-462F156E94A0Q40656728-365DFC26-3841-45D7-BDE2-5E72848E3FCAQ40735913-B8A49E08-2B1C-4AE9-9A0E-99310362CFFEQ41381369-FA8B2CD2-3C63-4C83-90DB-254BA1B19F95Q41394095-3FB98988-A165-4169-B521-D082DAC9A855Q41637999-D1B849C9-8B22-4F62-BAEF-52E0DA78E5CAQ41928514-720EAD41-84F6-4B6B-9811-C4920657DD6EQ42244826-937D49DB-7F34-46F6-BF39-FBFB61539775
P50
description
researcher, ORCID id # 0000-0002-6041-5166
@en
wetenschapper
@nl
name
Shawn G Gibbs
@ast
Shawn G Gibbs
@en
Shawn G Gibbs
@es
Shawn G Gibbs
@nl
type
label
Shawn G Gibbs
@ast
Shawn G Gibbs
@en
Shawn G Gibbs
@es
Shawn G Gibbs
@nl
prefLabel
Shawn G Gibbs
@ast
Shawn G Gibbs
@en
Shawn G Gibbs
@es
Shawn G Gibbs
@nl
P106
P1153
7103264117
P31
P496
0000-0002-6041-5166